Event Participants
Executives
3 Rajesh Rathi (Chairman and Managing Director), Amitabh Mukhopadhyay (Non-Independent Non-Executive Director), Neelkanth Nathu (Chief Financial Officer)
Analysts
8 Ankur Periwal (Axis Capital), Archit Joshi (Nuvama), Nitesh Dhoot (Anand Rathi), Pratham Kankaria (Quantum AMC), Rajesh Rathi, Rohit Nagraj (360 ONE Capital), Sanjesh Jain (ICICI Securities), Rashmi Goyal (Orient Capital), Viraj Mahadevia (MoneyGrow)
Note: One unidentified participant also asked a question.
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue from Operations | ₹2,642 crores | +60% YoY for one Sudarshan Chemical Industries (incl. RECO); ~5% revenue growth YoY |
| Business EBITDA (one Sudarshan) | ₹247 crores | +60%+ YoY growth; excludes inventory change impact |
| Reported EBITDA (one Sudarshan) | ₹266 crores | Strong reported performance for combined entity |
| Business EBITDA (Acquired Group) | ₹128 crores | Up from ₹65 crores YoY—nearly doubled; reported EBITDA ₹146 crores vs ₹78 crores YoY |
| Legacy SCIL Revenue Growth | 12-13% growth | Benchmark growth figure maintained for legacy business |
| Acquired Group Revenue Growth | +5% YoY | Despite geopolitical headwinds and logistics cycle extension of 2 weeks |
| EPS (Quarter, non-annualized) | ₹12.30 per share | Reported for combined entity |
| ROCE | 22.7% | Annualized basis; management notes it's annualized number |
| Net Debt | ₹531 crores | Reduced from ₹922 crores peak (18 months ago); ~60% reduction from peak; net debt-to-equity at 0.2 |
| Net Working Capital | 23.6% | On annualized basis; management targeting cash release from working capital |
| Gross Margin | 54%+ | QoQ improvement of ~2%; driven by yield improvements, utilities, production cost reduction; Q1 included minor one-off benefits; expected to remain 50%+ |
| RECO Business Revenue | ₹38 crores | Weak quarter due to customer site readiness delays and subcontracting manpower availability |
Geographic & Segment Commentary
Acquired Group (Clariant/Heubach - now "one Sudarshan Chemical Industries") The acquired group recorded strong EBITDA growth—business EBITDA up from ₹65 crores to ₹128 crores YoY, with reported EBITDA improving from ₹78 crores to ₹146 crores. Revenue grew 5% despite geopolitical disruptions including energy cost spikes in Europe and India, raw material cost inflation, and logistics cycle extension by 2 weeks. Management noted customers are delaying purchases and avoiding inventory buildup due to uncertainty; procurement has maintained safety stock levels while supply chain manages inventory positioning. The inventorized overhead impact of increased inventory was ₹18 crores in Q1.
Legacy Sudarshan Chemical Industries (India) Legacy business delivered 12-13% revenue growth, continuing its benchmark performance trajectory. Intercompany business transfers from Germany to India contributed partially to the India business growth. Management noted this includes both producing in India and selling domestically, and vice versa.
RECO Business Q1 revenue was weak at ₹38 crores due to delays in customer site readiness and subcontracting manpower availability challenges. EBITDA declined accordingly. Management expects normalization from the current quarter onwards and is confident RECO will post positive numbers before year-end. Transformation journey continues with hiving-off still under consideration.
Application Segments (Coatings, Plastics, Inks, Specialties) Coatings markets in both US and Europe (decorative and automotive) remain subdued. Plastics demand impacted by substantial polymer price increases due to geopolitical situation—customers avoiding high-cost inventories, creating hand-to-mouth supply cycles. Printing inks volume-driven market declining long-term due to digitalization, though specialty applications with stringent packaging regulations are growing. Specialty applications (agro, digital) showing good growth.
Company-Specific & Strategic Commentary
HOIBEX Acquisition Integration (Project Indica - OneSAP) Company merged with Clariant's Earth White, Clariant, and Fibroc businesses ~18 months ago (March 2025), forming a global pigment leader with 19 manufacturing sites across 11 countries on 5 continents, 1,600+ products, and 4,000+ global customers. Project Indica (OneSAP implementation) is well advanced and expected to go live during FY27, replacing 4+ different SAPs and 130+ applications. Second global headquarters established in Frankfurt. Global capability center set up in Pune with centers of excellence being built.
Value Capture and Cost Reduction Value capture remains a key priority driving profitability growth—management noted substantial value capture is still flowing into numbers and the journey will continue through FY27-28. Cost reduction initiatives include yield improvements, utilities optimization, and production efficiency gains. Management attributed Q1 gross margin improvement largely to these initiatives.
Balance Sheet Deleveraging Net debt reduced from ₹922 crores peak to ₹531 crores in less than 18 months—a 60% reduction. Management expects to accelerate repayment of acquisition debt as net debt position improves. Targeting debt-free status as aspiration (from ~₹800-1,000 crores net debt 2-3 years ago vs ₹531 crores now).
Ownership Structure Rationalization Company acquiring 70% stake in Sudarshan Chemical Industries from overseas subsidiaries—this was planned at acquisition time for financing simplicity. It's a holding structure rationalization within the group with no impact on control or business operations.
Employee Restructuring Program Post June 30, a wholly-owned subsidiary signed an agreement with an employee representative body (European Works Council) for employee restructuring. Quantification not yet possible; clarity expected by end of Q2. Management indicated charge is "quite routine" and could not provide EBITDA guidance impact yet.
CapEx Strategy No new CapEx needed for volume growth—existing capacity sufficient for targeted growth. Only special initiatives (backward integration, special projects) considered, evaluated strictly on ROI. Expect only moderate CapEx levels.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Revenue (Acquired Group) | $700 million for FY27 | Maintained despite Q1 outperformance; not revising guidance given geopolitical uncertainty; will revisit after Q2 |
| EBITDA (Acquired Group) | $35 million for FY27 | Maintained; Q1 performance much stronger than implied run-rate but management adopting wait-and-watch approach |
| One Sudarshan Revenue Outlook | ₹12,000+ crores | Long-term trajectory per investor deck slide 9; driven by capturing lost business and market share gains |
| Acquired Group EBITDA Margins | High single digits to low double digits | Target path; management noted historical double-digit margin achievement and value capture driving improvement through FY27-28 |
| EBITDA Growth Journey | 7x of FY23 EBITDA aspiration | From ₹200-250 crores EBITDA in FY23 to target; combined with debt-free level aspiration |
| RECO Business | Positive numbers before year-end | Expected normalization from current quarter; transformation continuing |
| Guidance Revision | After Q2 FY27 | Management will reconsider guidance post-Q2 results |
Risks & Constraints
| Risk | Context |
|---|---|
| Geopolitical Disruption Impacting Demand | Middle East crisis causing energy cost spikes across Europe and India, raw material cost inflation, and logistics cycle extension of ~2 weeks. Customers across industries delaying purchases to avoid inventory buildup. Management mitigating via safety stock, optimized inventory positioning, and close customer engagement. |
| Volume Decline Risk in Q1 | Analyst inference that underlying volumes declined in Q1 when adjusted for currency translation and price increases. Management disputed this, citing broad product range (1-130+ product grades) making volume measurement difficult, and noting Q1 last year included sales brought forward from go-live of acquired entity SAP systems. |
| Raw Material Price Sustainability | Price increases taken only as pass-through of cost inflation—no opportunistic pricing. If crude/raw material prices soften, price reversals would follow, potentially impacting margins. Management guided gross margins to remain 50%+ even with normalization. |
| RECO Business Execution Challenges | Customer site readiness delays and subcontractor manpower shortages impacted Q1 revenue and EBITDA. Management expects normalization from Q2 and positive contribution by year-end. |
| Employee Restructuring Charge | European Works Council agreement signed post-June 30 for restructuring; quantification pending. Expected clarity by Q2 end; management characterized as "routine" but acknowledged no current visibility on impact to FY27 EBITDA guidance. |
| Q3 Seasonality | Management noted seasonality typically seen in Q3, which may impact full-year performance despite strong Q1 start. |
| Inks Market Structural Decline | Printing inks volume-driven market declining due to digitalization; partially mitigated by growth in specialty applications and regulatory-driven packaging requirements. |
| Complex Integration Risk | 4+ different SAPs and 130+ applications still operational; Project Indica go-live in FY27 is critical to unlock efficiency. Technically complex transition with execution risk. |
Q&A Highlights
Volume Growth and Guidance Confidence
- Question: Q1 underlying volumes may have declined once adjusting for currency translation and price pass-through—what gives confidence in sustained 20%+ growth? (Sanjesh Jain, ICICI Securities)
- Answer: Volume inference may not be accurate given product complexity across 1-130+ grades. Revenue grew ~6% despite geopolitical situation, and growth base was higher last Q1 due to SAP go-live timing on acquired entities. Confidence driven by: value capture still flowing into numbers (fully in company's control), and significant opportunity to recover lost business from pre-integration period due to insolvency issues and lack of focus. (Rajesh Rathi)
EBITDA Growth Drivers: Revenue vs Value Capture
- Question: Going from ₹800-1,500 crores EBITDA, how much is revenue growth vs value capture? (Sanjesh Jain, ICICI Securities)
- Answer: Substantial portion of EBITDA growth will come from cost reduction/value capture rather than revenue growth. (Rajesh Rathi)
Capacity and CapEx
- Question: Where are we in utilization cycle and any large CapEx needs for product development or backward integration in next 12-18 months? (Sanjesh Jain)
- Answer: No new CapEx needed for volume growth—existing capacity sufficient. Only special initiatives like backward integration considered based on ROI; expect only moderate CapEx. (Rajesh Rathi)
Gross Margin Sustainability
- Question: Q1 gross margin at 54% highest level, any benefit from low-cost inventory, and impact if raw material prices reverse? (Sanjesh Jain)
- Answer: Gross margin movement QoQ was ~2%, primarily from cost reductions in yields, utilities, production. Minor one-off items exist. Margins should continue at 50%+ level. (Rajesh Rathi)
Guidance Phasing and Revenue Mix
- Question: Revenue annualized at ₹10,600+ crores exceeds ₹9,800-10,200 crores FY27 guidance top end; is there upside bias? How much of Q1 was one-off? (Rashmi Goyal, Orient Capital)
- Answer: Results are solid with minimal one-offs—hence the business EBITDA disclosure. However, given geopolitical situation, adopting wait-and-watch approach and will revisit guidance after Q2. Not revising currently. (Rajesh Rathi)
Acquired Group Margin Trajectory
- Question: Is 6-7% margin the new steady state or is there a path back to 15%+ legacy-like margins? (Rashmi Goyal)
- Answer: Guidance doesn't imply reaching 15%; target for acquired group is high single digits to low double digits. (Rajesh Rathi)
RECO Business and Debt Repayment
- Question: What are debt repayment plans and revised thoughts on RECO hiving off? (Ankur Periwal, Axis Capital)
- Answer: Net debt position improving; expect to accelerate acquisition debt repayment. RECO faced construction challenges due to subcontractor labor issues; normalization expected from current quarter with positive numbers before year-end. Transformation continues. (Neelkanth Nathu)
Value Capture Timeline
- Question: Over what timelines will value capture synergies be achieved—by FY28 or into FY29? (Ankur Periwal)
- Answer: Major portion of value capture will be delivered in FY27-28, with some flowing into FY29. (Rajesh Rathi)
Price Increases and Sustainability
- Question: Have material price increases been taken and will they sustain? (Rohit Nagraj, 360 ONE Capital)
- Answer: Price increases only passed through cost increases—no advantage taken of demand-supply dynamics. If raw material and oil prices soften, will reverse prices accordingly. (Rajesh Rathi)
Heubach Acquisition Revenue Recapture
- Question: Heubach was a €1 billion business pre-troubles; can you build another Sudarshan Chemical Industries out of this in revenue, or being selective on growth? (Viraj Mahadevia, MoneyGrow)
- Answer: Heubach lost substantial business post-integration. Market share caps growth at market size, but significant opportunity exists in recapturing lost business—this drives revenue projections. Investor deck slide 9 shows path to ₹12,000+ crores. EBITDA improvement driven by cost reduction and lean operations. (Rajesh Rathi)
Product Transfers from Germany
- Question: Is India business growth partly from transferring products from Germany base? (Pratham Kankaria, Quantum AMC)
- Answer: Partially correct—some intercompany business transfers from Germany contributed to India growth, both producing/selling in India and vice versa. (Rajesh Rathi)
Stake Acquisition Rationale
- Question: What's behind acquiring 70% stake in Sudarshan Chemical Industries from overseas subsidiaries—cash transfer for deleveraging? (Nitesh Dhoot, Anand Rathi)
- Answer: Decision was planned at acquisition time—used indirect acquisition for financing simplicity. This is holding structure rationalization with no impact on control or business. (Neelkanth Nathu)
Employee Restructuring Charge
- Question: Note 9 mentions post-June 30 subsidiary agreement with employee representative body for restructuring—is this a European Works Council deal, how much and is it in FY27 EBITDA guidance? (Nitesh Dhoot)
- Answer: Quantification not yet possible; clarity expected by end of Q2. Numbers are "quite routine" but more color can be provided next quarter. (Neelkanth Nathu)
End Market Demand Outlook
- Question: Thoughts on outlook for paints, packaging, plastics, inks, and new specialty applications post-Heubach acquisition? (Archit Joshi, Nuvama)
- Answer: Coatings (decorative and automotive) subdued in US and Europe. Plastics impacted by polymer price increases—value chain dried up, hand-to-mouth supply behavior. Printing inks volume-driven market declining long-term due to digitalization; specialty packaging applications growing. Specialty applications (agro, digital) showing good growth. (Rajesh Rathi)
Raw Material Basket Changes
- Question: How has RM basket widened post-acquisition, particularly for specialty pigments? (Archit Joshi, Nuvama)
- Answer: RM categories (benzene, toluene, acetic acid, aniline-driven) haven't changed, but product mix shifted—high-performance pigments and pigment dispersion business grown substantially, making phosphorus-driven categories more important. Specific categories can be shared offline with purchasing. (Rajesh Rathi)
Pricing Model and Contracts
- Question: How do contracts work—long-term or short-term, and ability to pass through RM prices? (Unidentified Participant)
- Answer: Business is sticky—changing pigments in coatings takes 1-2 years typically, up to 5 years for automotive paint. Quarterly price negotiations preferred; pass-through of increases during geopolitical/raw material volatility. (Rajesh Rathi)
Key Takeaway
Sudarshan Chemical Industries delivered a robust Q1 FY27 with revenue of ₹2,642 crores and business EBITDA of ₹247 crores (+60%+ YoY), driven by 12-13% legacy business growth, 5% acquired group growth, and continued value capture initiatives. The acquired group's business EBITDA nearly doubled YoY to ₹128 crores, reflecting successful integration of Heubach/Clariant businesses. Net debt reduced to ₹531 crores from ₹922 crores at acquisition, with net debt-to-equity at 0.2 and ROCE at 22.7%. Despite Q1 outperformance, management maintained FY27 guidance (acquired group $700M revenue/$35M EBITDA) due to geopolitical uncertainty, adopting a wait-and-watch approach with revision possible post-Q2. Strategic priorities include completing Project Indica (OneSAP), accelerating value capture through FY27-28, and RECO business turnaround targeting positive numbers by year-end. Key watch points: geopolitical impact on customer demand, raw material price direction (reversals would reduce pass-through pricing), employee restructuring charge quantification, Q3 seasonality, and progress on recapturing Heubach's lost business toward the ₹12,000+ crore revenue trajectory.